BILLY; Eric

Patent Applications and Registrations

Patent applications and USPTO patent grants for BILLY; Eric.The latest application filed is for "compositions and methods to treat cancer".

Company Profile

1.9.9

BILLY; Eric - Basel CH
Billy; Eric - Chatenois N/A FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods To Treat Cancer App 20210155932 - BILLY; Eric ; et al.	2021-05-27
Short interfering ribonucleic acid (siRNA) for oral administration Grant 9,493,771 - Natt , et al. November 15, 2	2016-11-15
SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION App 20150259675 - NATT; Francois Jean-Charles ; et al.	2015-09-17
Short interfering ribonucleic acid (siRNA) for oral administration Grant 8,957,041 - Natt , et al. February 17, 2	2015-02-17
Short Interfering Ribonucleic Acid (siRNA) for Oral Administration App 20130230923 - NATT; Francois Jean-Charles ; et al.	2013-09-05
Short interfering ribonucleic acid (siRNA) for oral administration Grant 8,404,832 - Natt , et al. March 26, 2	2013-03-26
Short interfering ribonucleic acid (siRNA) for oral administration Grant 8,404,831 - Natt , et al. March 26, 2	2013-03-26
Short interfering ribonucleic acid (siRNA) for oral administration Grant 8,344,128 - Natt , et al. January 1, 2	2013-01-01
Short Interfering Ribonucleic Acid (siRNA) for Oral Administration App 20120029052 - NATT; Francois Jean-Charles ; et al.	2012-02-02
Short Interfering Ribonucleic Acid (siRNA) for Oral Administration App 20120029053 - NATT; Francois Jean-Charles ; et al.	2012-02-02
Short Interfering Ribonucleic Acid (siRNA) for Oral Administration App 20120022139 - NATT; Francois Jean-Charles ; et al.	2012-01-26
Short interfering ribonucleic acid (siRNA) with improved pharmacological properties Grant 8,084,600 - Natt , et al. December 27, 2	2011-12-27
Inhibition Of Gpr4 App 20100144835 - Seuwen; Klaus ; et al.	2010-06-10
Methods of inhibiting expression of a target gene in mammalian cells App 20040235764 - Billy, Eric ; et al.	2004-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.